Barr Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for BARR, and what generic and branded alternatives to BARR drugs are available?
BARR has one hundred and seventy-five approved drugs.
There are seven tentative approvals on BARR drugs.
Drugs and US Patents for Barr
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Barr Labs Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 079031-002 | Jul 13, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Barr | LEUCOVORIN CALCIUM | leucovorin calcium | TABLET;ORAL | 071198-001 | Sep 24, 1987 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Barr | TREXALL | methotrexate sodium | TABLET;ORAL | 040385-004 | Mar 21, 2001 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.